These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 37062051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T.
    Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
    [Abstract] [Full Text] [Related]

  • 5. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
    Bera R, Chiu MC, Huang YJ, Lin TH, Kuo MC, Shih LY.
    J Hematol Oncol; 2019 Oct 22; 12(1):104. PubMed ID: 31640815
    [Abstract] [Full Text] [Related]

  • 6. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.
    Fei F, Jariwala A, Pullarkat S, Loo E, Liu Y, Tizro P, Ali H, Otoukesh S, Amanam I, Artz A, Ally F, Telatar M, Nakamura R, Marcucci G, Afkhami M.
    Int J Mol Sci; 2024 Sep 23; 25(18):. PubMed ID: 39337700
    [Abstract] [Full Text] [Related]

  • 7. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E, Yang F, Traer E, Arora R, Brown S, Rattray R, Braziel R, Fan G, Press R, Dunlap J.
    Am J Clin Pathol; 2016 Apr 23; 145(4):497-506. PubMed ID: 27124934
    [Abstract] [Full Text] [Related]

  • 8. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
    Asada S, Kitamura T.
    Int J Hematol; 2019 Aug 23; 110(2):179-186. PubMed ID: 30515738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 23; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C, Burillo-Sanz S, Morales-Camacho RM, Pérez-López O, Suito M, Vargas MT, Caballero-Velázquez T, Carrillo-Cruz E, González J, Bernal R, Pérez-Simón JA.
    Cancer Med; 2020 Jun 23; 9(11):3637-3646. PubMed ID: 32216059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
    Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.
    Br J Haematol; 2009 Jun 23; 145(6):788-800. PubMed ID: 19388938
    [Abstract] [Full Text] [Related]

  • 15. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y, Harada H.
    Rinsho Ketsueki; 2016 Feb 23; 57(2):147-55. PubMed ID: 26935632
    [Abstract] [Full Text] [Related]

  • 16. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia.
    D'Altri T, Wilhelmson AS, Schuster MB, Wenzel A, Kalvisa A, Pundhir S, Meldgaard Hansen A, Porse BT.
    Haematologica; 2021 Apr 01; 106(4):1000-1007. PubMed ID: 32381577
    [Abstract] [Full Text] [Related]

  • 17. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
    Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, Nguyen L, Yuan J, Jiang L, Yang X, Weeks O, Liu Z, Zhou J, Ni H, Cai CL, Xu M, Yang FC.
    Blood; 2014 Jan 23; 123(4):541-53. PubMed ID: 24255920
    [Abstract] [Full Text] [Related]

  • 18. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia.
    Man N, Mas G, Karl DL, Sun J, Liu F, Yang Q, Torres-Martin M, Itonaga H, Martinez C, Chen S, Xu Y, Duffort S, Hamard PJ, Chen C, Zucconi BE, Cimmino L, Yang FC, Xu M, Cole PA, Figueroa ME, Nimer SD.
    JCI Insight; 2021 Oct 08; 6(19):. PubMed ID: 34622806
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ, Pan LJ, Qin TJ, Xu ZF, Li B, Wang HJ, Sun Q, Jia YJ, Li CW, Cai WY, Gao QY, Jiao M, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):373-379. PubMed ID: 37550186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.